Simplify Logo
Watchmaker Genomics

Watchmaker Genomics

High-performance enzymes for genomics workflows

Associate Director - Product Marketing

Full-Time
$150k - $170k/yr

+ Bonus + Equity

Expert
Master's
Boulder, CO, USA
Remote

Boulder candidates are preferred; the role is also fully remote.

About the job

Requirements
  • An MS in Molecular Biology, Biochemistry, Genetics, Genomics, or a related scientific discipline is required.
  • A minimum of 12 years of relevant industry experience in life sciences, biotechnology, or molecular diagnostics is required.
  • Two to four years of people management experience with demonstrated success developing high-performing teams is required.
  • Demonstrated experience leading product commercialization and product marketing initiatives is required.
  • Experience participating in or leading cross-functional new product development teams is required.
  • Strong understanding of genomics, molecular diagnostics, or related technologies is required.
  • Demonstrated success leading and developing high-performing Product Marketing teams is required.
  • Proven experience leading product commercialization and go-to-market initiatives in the life sciences, biotechnology, or molecular diagnostics industry is required.
  • A strong scientific foundation and the ability to translate complex technical concepts into compelling customer value propositions are required.
  • Excellent scientific writing, communication, and presentation skills are required.
  • Experience developing product positioning, messaging, sales enablement, and commercialization strategies is required.
  • Ability to influence and collaborate effectively across Product Management, R&D, Applications, Commercial, Marketing Communications, and Executive Leadership is required.
  • Strong customer and market orientation, including experience incorporating customer insights and competitive intelligence into commercial strategy, is required.
  • A data-driven mindset with experience measuring commercialization effectiveness and marketing performance is required.
  • Excellent organizational and project management skills, with the ability to prioritize multiple strategic initiatives in a fast-paced environment, are required.
  • Willingness to travel up to 25% domestically and internationally is required.
Responsibilities
  • Lead, mentor, and develop a high-performing Product Marketing team.
  • Foster a collaborative, customer-focused culture while setting clear goals, priorities, and performance expectations.
  • Allocate team resources to support commercialization priorities across the portfolio.
  • Lead the Product Marketing team in developing and executing commercialization strategies across the genomics and molecular diagnostics portfolios.
  • Own the overall product positioning framework and unified communication strategy across products, campaigns, and customer touchpoints.
  • Guide cross-functional go-to-market planning and lifecycle marketing strategies, including positioning, messaging, launch strategy, and sales enablement.
  • Ensure successful commercialization through close partnership with Product Management, Commercial, Applications, R&D, and Operations.
  • Oversee development of scientific content and technical marketing assets communicating differentiated product value.
  • Guide technical marketing priorities, including customer collaborations, technical data generation, and publication strategy.
  • Ensure scientific accuracy and consistency across customer-facing marketing materials.
  • Support digital marketing initiatives, including demand generation, lead management, and e-commerce, to expand market reach and support revenue growth.
  • Partner with Product Management to align commercialization activities with portfolio strategy and product roadmaps.
  • Provide strategic direction for partnerships with Marketing Communications, Sales, Applications, and Executive Leadership.
  • Incorporate customer insights, competitive intelligence, and market trends into commercialization planning.
  • Establish commercialization priorities and marketing investments that support portfolio growth.
  • Monitor marketing performance and optimize programs using data-driven insights.
  • Contribute to annual commercial planning and continuous improvement of marketing processes.
Desired Qualifications
  • Customer-facing experience in Product Management, Field Applications, Technical Marketing, or Sales is preferred.

About the company

Watchmaker Genomics develops specialized enzymes and tailored solutions used to read, write, and edit DNA for high-growth molecular biology companies. These enzymes act as biological tools that drive critical workflows like DNA sequencing and synthesis, supported by custom manufacturing and quality control processes. The company distinguishes itself through a leadership team with deep industry experience in enzyme supply chains and a focus on creating bespoke products through collaborative research partnerships. Its goal is to accelerate genomic research and diagnostics by providing high-performance tools that improve the speed and accuracy of genetic data processing.

Company Size

201-500

Company Stage

Series A

Total Funding

$48.3M

Headquarters

Boulder, Colorado

Founded

2019

Get referred to Watchmaker Genomics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 2026 Boulder lease more than doubles capacity and signals customer demand.
  • Callisto Complete Kit and ESHG 2026 launches broaden partnerships with Volta Labs and diagnostics developers.
  • Workforce growth above 35% in 12 months shows hiring momentum before 2027 startup.

What critics are saying

  • biomodal's November 2025 Colorado lawsuit threatens TAPS+ sales, injunctions, and licensing costs.
  • Boulder capacity stays offline until second-half 2027, delaying revenue while lease expense starts now.
  • Any TAPS+ injunction would cripple a flagship product and expose Watchmaker's platform credibility.

What makes Watchmaker Genomics unique

  • Trey Foskett and Stephen Picone built Watchmaker on proven Enzymatics and Kapa playbooks.
  • ISO 13485 quality systems and Cape Town manufacturing support regulated diagnostics customers.
  • Engineered enzymes target sequencing bottlenecks across PCR-free, normalization, and error-correction workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Flexible Work Hours

Paid Parental Leave

401(k) Retirement Plan

401(k) Company Match

Employee Assistance Program

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-2%

2 year growth

-2%
BizWest Media LLC
Sep 2nd, 2026
Watchmaker Genomics leases 100K SF in Boulder's Flatiron Park.

Watchmaker Genomics leases 100K SF in Boulder's Flatiron Park. Life-sciences firm Watchmaker Genomics Inc. has more than doubled its manufacturing capacity with a recently inked lease for about 100,000 square feet of production space in Boulder's Flatiron Park business campus. Already have a paid subscription? A Maryland native, Lucas has worked at news agencies from Wyoming to South Carolina before putting roots down in Colorado.

BridgeTower Media
Sep 1st, 2026
SENS doubles Longmont manufacturing space with new 105,000-square-foot facility.

SENS doubles Longmont manufacturing space with new 105,000-square-foot facility. Watchmaker Genomics leases 100,000-square-foot facility in Boulder. In brief: * Watchmaker Genomics signs lease for 100,000 square feet * Facility located at Flatiron Park in Boulder * Expansion expected to create hundreds of Colorado jobs * CEO Trey Foskett highlights investment in manufacturing capabilities BOULDER, Colo. - Watchmaker Genomics has signed a long-term lease for about 100,000 square feet at Flatiron Park in Boulder, a move the company said will more than double its manufacturing capacity. The facility is expected to begin operating in the second half of 2027 after construction and qualification are completed. Watchmaker said the expansion could create hundreds of Colorado jobs, with hiring occurring in phases. The Boulder-based company develops and manufactures reagents used in genomics and molecular diagnostics. The new facility will house manufacturing, research and development, quality and operations teams. It also will support work governed by the company's ISO 13485-certified quality management system. "We are investing in the infrastructure, quality systems and manufacturing capabilities required to serve genomics and molecular diagnostics companies at commercial scale," CEO and co-founder Trey Foskett said. Watchmaker said its Colorado workforce has grown by more than 35% during the past year. The Boulder expansion will complement its operations in Cape Town, South Africa. Chris Wiley of Colliers represented Watchmaker in the lease transaction. Blake Harris and Erik Abrahamson of CBRE represented the landlord.

Watchmaker Genomics
Sep 1st, 2026
Watchmaker Genomics expands Boulder Manufacturing campus to more than double manufacturing capacity.

Watchmaker Genomics expands Boulder Manufacturing campus to more than double manufacturing capacity. - September 01, 2026 100,000-square-foot facility will support growing customer demand and create hundreds of new Colorado jobs. BOULDER, Colo. - Watchmaker Genomics, a developer and manufacturer of precision reagents for genomics and molecular diagnostics, today announced that it has signed a long-term lease for approximately 100,000 square feet at Flatiron Park in Boulder, Colorado. The facility will more than double Watchmaker's manufacturing capacity and provide room for continued growth across R&D, quality, logistics, and other key functions. The expansion is expected to support hundreds of new Colorado jobs over the coming years, with hiring occurring in phases as the campus comes online. The site is expected to become operational in the second half of 2027, following completion and qualification. As customer demand continues to grow, the new campus will provide the capacity and infrastructure needed to support reliable supply worldwide. The expanded facility will support customers from initial development through to commercialization. "This is an important milestone for Watchmaker," said Trey Foskett, Chief Executive Officer and Co-Founder of Watchmaker Genomics. "We are investing in the infrastructure, quality systems, and manufacturing capabilities required to serve leading genomics and molecular diagnostics companies at commercial scale. It reflects our confidence in the future of precision genetic testing, the strength of our team, and Boulder as a place to build a world-class life science company." The Flatiron Park facility will serve as the Watchmaker Boulder Manufacturing Center of Excellence for reagent manufacturing and will house the company's manufacturing, quality, R&D, and operations teams. It will also support the expansion of activities governed by Watchmaker's ISO 13485-certified quality management system. Watchmaker's decision to expand in Boulder underscores Colorado's Front Range region as a center for scientific innovation, advanced manufacturing, and entrepreneurship. The investment reflects Watchmaker's long-term commitment to Colorado, where the company's workforce has grown by more than 35% in the last 12 months. Building on continued growth at Watchmaker's Cape Town operations, the new Boulder campus further develops the company's globally connected research, development, and manufacturing network. Together, the sites support customers and partners across North America, Europe, and Asia. The expansion comes during a period of significant momentum for Watchmaker Genomics, marked by the launch of several new genomics solutions over the past year and receipt of the Governor's Award for Excellence in Exporting, recognizing the company's international growth and contribution to Colorado's economy. "This expansion is about more than square footage," said Brian Deneau, Chief Financial and Operating Officer of Watchmaker Genomics. "It creates the operational foundation for our next stage of growth and strengthens our ability to pair technical innovation with rigorous quality systems and dependable manufacturing." Chris Wiley of Colliers represented Watchmaker Genomics in the lease transaction. Blake Harris and Erik Abrahamson with CBRE represented the landlord. About Watchmaker Genomics. Watchmaker Genomics is a life sciences company focused on developing high-performance tools that empower genomic research and clinical applications. Leveraging expertise in protein engineering and next-generation sequencing, Watchmaker delivers precision reagents and platforms that enable superior accuracy, efficiency, and cost-effectiveness in molecular analysis. The company is dedicated to advancing breakthrough technologies to support innovations in cancer detection, epigenetics, and liquid biopsy applications. Media contacts. Watchmaker Genomics Jen Pavlica VP, Marketing [email protected] Sciad Communications, Media Relations Jasmin Shearan [email protected] +442034057892

The Montreal Gazette
Jun 9th, 2026
Watchmaker to unveil new technologies addressing NGS workflow bottlenecks and sequencing accuracy challenges at ESHG 2026.

Watchmaker to unveil new technologies addressing NGS workflow bottlenecks and sequencing accuracy challenges at ESHG 2026. New technologies advance scalable library normalization for high-throughput genomics labs and improved amplification accuracy for oncology-focused sequencing workflows where data quality is critical BOULDER, Colo. - Watchmaker Genomics, a leader in high-performance NGS workflow solutions, today announced it will unveil two new technologies at the European Society of Human Genetics (ESHG) 2026 conference, designed to...

Business Wire
Jun 9th, 2026
Watchmaker unveils Cas9-based library normalisation kit and high-accuracy amplification mix at ESHG 2026

Watchmaker Genomics will unveil two technologies at the European Society of Human Genetics 2026 conference addressing sequencing workflow challenges. The EquiPlex Normalization Kit uses a Cas9-based approach to simplify library normalization by capturing fixed molecules from each library, eliminating concentration quality control and dilution steps. The technology is compatible with RNA-seq, DNA-seq and methylation sequencing workflows. The company will also debut Equinox Prime Library Amplification Master Mix, designed to reduce polymerase slippage in homopolymer and repetitive genomic regions. The solution improves variant calling accuracy for applications like microsatellite instability profiling whilst delivering low error rates, high yields and uniform GC coverage. Both technologies reflect Watchmaker's focus on solving sequencing workflow bottlenecks and improving data quality at scale.